Omnicare
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Omnicare's revenues will wane -0.1% and EPS will expand 38.1%.
The average estimate for revenue is $1.54 billion. On the bottom line, the average EPS estimate is $0.87.
Revenue details
Last quarter, Omnicare reported revenue of $1.53 billion. GAAP reported sales were 4.3% lower than the prior-year quarter's $1.59 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
Last quarter, non-GAAP EPS came in at $0.90. GAAP EPS of $0.51 for Q1 were 6.3% higher than the prior-year quarter's $0.48 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Recent performance
For the preceding quarter, gross margin was 24.3%, 120 basis points better than the prior-year quarter. Operating margin was 9.5%, 50 basis points better than the prior-year quarter. Net margin was 3.6%, 10 basis points better than the prior-year quarter.
Looking ahead
The full year's average estimate for revenue is $6.14 billion. The average EPS estimate is $3.56.
Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 221 members out of 241 rating the stock outperform, and 20 members rating it underperform. Among 92 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 90 give Omnicare a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Omnicare is outperform, with an average price target of $43.50.
Is Omnicare the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Omnicare to My Watchlist.